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It is widely accepted that human papillomavirus (HPV) is the
primary causative agent of cervical neoplasia (cervical intraepi
thelial neoplasia [CIN] and invasive cancer) (zur Hausen, 1991).
However, HPV infection of the uterine cervix does not always
induce cellular abnormalities (de Villiers et al, 1987), suggesting
that other factors play a role in the development of cervical
neoplasia. Many epidemiologic factors have been suggested as
relevant to the development of cervical neoplasia (Rotkin, 1973;
Bornstein et al, 1995). We conducted a case-control study to
clarify how epidemiologic factors are involved in the development
of CIN in relation to HPV infection.
MATERIALS AND METHODS
Study population
The study population consisted of women aged 55 or younger who
underwent Papanicolaou test screening at nine hospitals between
June 1995 and July 1996. For women with abnormal cervical
cytology, colposcopically directed biopsies were performed. The
cases enrolled in the study were women in whom CIN was first
detected during the study period. A total of 167 women who had
histological evidence of CIN were included; low-grade CIN (CIN
I [n 5 94]) and high-grade CIN (CIN II [n 5 40] and CIN III [n 5
33]). We excluded carcinoma in situ from CIN III. The histological
review was performed by one experienced pathologist (KN).
Controls matched one-to-one with cases on age (within 5 years)
and hospital were selected from subjects who were found to have
normal cervical cytology. All CIN cases and controls gave written
informed consent.
The questionnaire
Information concerning health issues related to the possible aeti-
ology of CIN was obtained by a self-administered questionnaire.
The questionnaire, which included demographic factors, smoking
habits, contraceptive and reproductive history, and sexual behav-
iour, was distributed to each case or control on their second
hospital visit. Several participants gave no answers to certain
questions.
Detection and typing of HPV
Cellular DNA was extracted from cervical exfoliated cells by stan-
dard procedure. We used the consensus L1 primers, L1C1 (1 mM),
L1C2 (0.5 mM) and L1C2M (0.5 mM), for the polymerase chain
reaction (PCR) (Yoshikawa et al, 1991). HPV types were identi-
fied on the basis of the restriction fragment length polymorphism.
The assay can type at least 26 genital HPVs. HPV data were
not obtained from nine (5%) of CIN cases and 37 (22%) of
controls. HPV types were categorized into three groups of carcino-
genic potency according to then risk classification proposed by
Lorincz et al, (1992); i.e. high-, intermediate- and low-risk HPVs
(Table 1).
Blood sampling and serum antibody detection
A blood sample for serological assays of herpes simplex virus
(HSV), cytomegalovirus (CMV) and Chlamydia trachomatis (CT)
was collected from each subject. Blood sampling was not available
in 9 (5%) CIN cases and 5 (3%) controls. Antibodies were assayed
by using commercially available enzyme-linked immunosorbent
assay (ELISA) kits; HSV and CMV (Denkaseiken, Niigata,
Japan), and CT (Labsystems Oy, Helsinki, Finland).
Data analysis
Odds ratios (ORs) and the corresponding 95% confidence inter-
vals (Cls) were calculated for each variable using conditional
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Correspondence to: H Yoshikawalogistic regression technique. Continuous variables were catego-
rized to allow ORs to be computed. Alongside crude ORs, we
calculated ORs after adjustment for HPV infection (HPV-adjusted
ORs). HPV infection and HPV-independent variables were
assessed by multivariate analysis. Tests for linear trend were
mainly performed on continuous variables. All the above-
mentioned statistical analyses were done using the SAS computer
software package (SAS Institute, Cary, NC, USA). Association
between two variables was analysed using a Spearman rank corre-
lation coefficient.
RESULTS
The mean ages of CIN cases and controls were 40.3 years and 40.7
years respectively. The age distribution was almost the same in the
two groups.
HPV infection
HPV DNA was detected much more frequently in CIN cases than
controls (Tables 1 and 2, OR 5 30.0). The incidence and types of
HPV detected in CIN cases and controls are shown in Table 1. In
the case of CIN as a whole, and high-grade CIN, no significant
differences in ORs were found across the three HPV subgroups
with different carcinogenic potentials (Table 2).
Risk factors before and after adjustment for HPV
infection
Of 16 study variables, the following nine showed statistically
significant differences between cases and controls before adjust-
ment for HPV infection: smoking, being married, early age at
marriage, multiple pregnancies, multiparity, early age at first preg-
nancy, multiple sexual partners, positive CT IgA and positive CT
IgG (Tables 3 and 4). Most of these risk factors were no longer
significant after adjustment and, in particular, the elevated risks
associated with smoking and multiple sexual partners disappeared
completely (HPV-adjusted OR , 1.0). In contrast, the associations
between being married, multiparity and early age at first preg-
nancy with CIN risk remained significant after adjustment.
The multivariate analysis for HPV infection and the three HPV-
independent variables confirmed that these factors were indepen-
dently and significantly associated with the risk of CIN (HPV
infection, OR 5 113; currently being married, OR 5 8.75, three
or more births, OR 5 4.00; 23 years or younger at first pregnancy
OR 5 7.79).
DISCUSSION
The present study confirmed that the highest risk determinant for
CIN was HPV infection. As expected, CIN patients had various
habitual, reproductive and sexual risk factors. However, these
factors, except for multiparity, early age at first pregnancy and
being married, were no longer significant after adjustment for
HPV infection.
The independent role of multiparity for development of CIN in
our study is of particular interest. Several recent studies control-
ling for HPV infection have also observed an association between
multiparity and risk of CIN (Schiffman et al, 1993; Becker et al,
1994). It was reported that progesterone enhances expression
of E6 and E7 oncoproteins through progesterone-responsive
elements of HPV (Chen et al, 1996). In addition, there is a recent
report suggesting that progesterone may impair T-cell recognition
of HPV-infected cells (Bartholomew et al, 1997). It seems likely
that higher levels of progesterone derived from the placenta may
be associated with CIN development.
Early age at first pregnancy has not been consistently shown to
be a risk factors in the previous studies. As expected, this factor
was closely correlated with early age at first birth (Spearman rank
correlation coefficient 5 0.87, P 5 0.0001). In a British study,
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Table 1 Detection of HPV DNA in controls and CIN cases
High risk Intermediate-risk Low risk
Lesions 16 18 31 33 51 52 56 58 59 68 70 6 42 53 54 61 66 Xa Ub HPV 1 (%)
Controls 1 1 2 0 1 5 2 1 1 0 1 0 0 1 0 1 0 2 0 19/130 (14.6)
Low-grade CIN 6 0 0 1 7 10 4 10 0 3 3 0 1 0 1 0 1 7 6 60/86 (69.8)
High-grade CIN 12 2 3 4c 4d 12 1 6cd 1 1 0 1 0 1 1 0 0 6 8 61/72 (84.7)
aUnknown HPV, btype-undertermined HPV, cdual infection in one case, ddual infection in another case.
Table 2 Relative risks (ORs) of CIN according to HPV test results
Controls CIN High-grade CIN II and III
HPV test results No. (%) No. (%) OR (95% CI) No. (%) OR (95% CI)
Negative 111 (85.4) 37 (23.4) 1.0 11 (15.2) 1.0
Positive 19 (14.6) 121 (76.6) 30.0 (9.5–94.8) 61 (84.7) 46.0 (6.3–333.6)
High-risk HPVs 2 (1.5) 20 (12.7) 109.6 (9.1–1320) 14 (19.4) 68.5 (4.1–1139)
Intermediate-risk HPVs 13 (10.0) 68 (43.0) 19.8 (6.1–64.4) 30 (41.6) 36.5 (4.2–316.2)
Low-risk HPVs 4 (3.1) 19 (12.0) 41.5 (6.1–283.6) 9 (12.5) 22.4 (1.8–270.0)
Type-undetermined HPV was excluded from the risk classification of HPV.early age at first birth was associated with an enhanced risk of
high-grade CIN (Cuzick et al, 1990). This factor was found to be
independent of multiparity and marital status in the multivariate
analysis. Thus, it is conceivable that the uterine cervix of young
pregnant women, mostly in concert with HPV, is more vulnerable
to the development of CIN.
Being married was found to be a HPV-independent risk factor
for CIN in this study. This factor was firstly described as a risk
factor of cervical cancer in Rigoni-Stern’s study in 1842 (Rotkin,
1973). It is to be noted that marital status was a risk factor inde-
pendent of multiparity in the multivariate analysis.
It is of interest that smoking was no longer a risk factor of CIN
after adjustment for HPV infections as in several recent studies
(Schiffman et al, 1993; Olsen et al, 1995). Other lines of research
have documented smoking as a risk factor for high-grade CIN
(Kjaer et al, 1998; Olsen et al, 1998), and the present data do not rule
out the possibility that smoking is a risk factor for CIN progression.
Lifetime number of sexual partners and age at first intercourse
turned out not to be risk factors after controlling for HPV infec-
tion. This suggests that sexual behaviour per se may be a risk
factor of HPV infection but not CIN, in keeping with previous
studies (Schiffman et al, 1993; Becker et al, 1994).
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Table 3 Relative risks (ORs) of CIN according to smoking history, marital status, reproductive history and sexual behaviour
Number of Crude OR OR adjusted for HPV
Variables cases/controls (95% CI) (95% CI)
Cigarette smoking
Never 106/119 1.00 1.00
Past 13/17 0.91 (0.42–1.98) 0.32 (0.08–1.27)
Current 41/24 2.04 (1.06–3.91) 0.81 (0.17–2.22)
Marital status
Never-married 12/23 1.00 1.00
Married 137/122 3.74 (1.36–10.32) 7.32 (1.06–50.43)
Separated/widowed 12/17 2.01 (0.59–6.91) 1.16 (0.10–13.37)
Age at marriage
–22 58/32 1.77 (1.01–3.12) 3.13 (0.91–10.8)
23–26 71/75 1.00 1.00
271 24/34 0.66 (0.34–1.28) 0.82 (0.23–2.90)
P for trend P 5 0.005 P 5 0.25
Number of pregnancies
0 8/23 0.46 (0.18–1.15) 0.14 (0.02–1.03)
1–2 39/91 1.00 1.00
31 77/57 1.82 (1.03–3.20) 2.72 (0.74–10.1)
P for trend P 5 0.002 P 5 0.07
Number of births
0 15/28 0.57 (0.27–1.19) 0.26 (0.05–1.23)
1–2 81/91 1.00 1.00
31 54/38 1.75 (1.01–3.03) 3.21 (1.03–10.0)
P for trend P 5 0.002 P 5 0.002
Age at first pregnancy
–23 76/46 1.84 (1.02–3.32) 4.42 (1.17–16.7)
24–26 42/47 1.00 1.00
271 34/42 0.83 (0.44–1.58) 1.75 (0.53–5.79)
P for trend P 5 0.001 P 5 0.14
Age at first birth
–24 70/43 1.76 (0.99–3.14) 1.31 (0.44–3.90)
25–27 45/51 1.00 1.00
281 23/35 0.62 (0.30–1.28) 0.38 (0.08–1.82)
P for trend P 5 0.002 P 5 0.06
Use of oral contraceptives
Never 152/151 1.00 1.00
Ever 10/12 0.91 (0.39–2.14) 0.93 (0.16–5.34)
Age at first intercourse
–18 19/17 0.85 (0.38–1.91) 0.11 (0.02–0.71)
19–23 114/94 1.00 1.00
241 30/53 0.50 (0.30–0.84) 0.53 (0.21–1.35)
P for trend P 5 0.03 P 5 0.74
Lifetime number of sexual partners
0–1 70/93 1.00 1.00
2–3 54/44 1.90 (1.11–3.30) 0.94 (0.36–2.43)
41 38/27 2.19 (1.12–4.30) 0.92 (0.26–3.22)
P for trend P 5 0.01 P 5 0.88Thus far, a limited number of studies have carried out sero-
logical analyses for sexually transmitted agents in the search of
risk factors of CIN. Certain studies found an independent role of
antibodies against CT or CMV as risk factors for high-grade CIN
(Koutsky et al, 1992; de Sanjose et al, 1994). Here we demon-
strated that the serological markers of HSV, CMV and CT were
not HPV-independent risk factors for CIN as in another recent
study (Ferrera et al, 1998).
In the present study, we focused on the analysis of risk factors in
the development of CIN. The results yield clues toward eluci-
dating the mechanism of the development of CIN in conjunction
with HPV. It is to be noted that risk factors for the progression of
CIN to cervical cancer may be different from those for CIN devel-
opment. To elucidate aetiologic factors for CIN progression, a
cohort study is underway.
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Table 4 Relative risks (ORs) for CIN according to selological variables
Number of Crude OR OR adjusted for HPV
Variables cases/controls (95% CI) (95% CI)
HSV (IgG)
Negative 33 46 1.00 1.00
Positive 125/116 1.67 (0.97–2.86) 2.03 (0.70–5.89)
HSV (IgM)
Negative 148/155 1.00 1.00
Positive 10/7 1.50 (0.53–4.21) 1.05 (0.19–5.78)
CMV (IgG)
Negative 5/11 1.00 1.00
Positive 153/151 2.20 (0.76–6.33) 9.66 (0.77–120.9)
CMV (IgM)
Negative 152/157 1.00 1.00
Positive 6/4 1.67 (0.40–6.97) 1.19 (0.09–15.7)
CT (IgA)
Negative 119/137 1.00 1.00
Positive 39/25 1.94 (1.08–3.49) 1.65 (0.60–4.51)
CT (IgG)
Negative 121/141 1.00 1.00
Positive 37/21 2.07 (1.12–3.83) 1.14 (0.41–3.15)